Velico Reports Positive Trial Results for FrontlineODP
BOSTON, Mass., June 20, 2026 Velico Medical has announced successful results from its Phase 1 first-in-human clinical trial evaluating...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BOSTON, Mass., June 20, 2026 Velico Medical has announced successful results from its Phase 1 first-in-human clinical trial evaluating...
MISSION VIEJO, Calif., June 20, 2026 Kyowa Hakko USA has unveiled promising new research demonstrating the potential acute cognitive...
